Our research · Bacterial AMR & One Health

Cameroon’s reference centre for bacterial antimicrobial resistance and One Health

CEDBCAM-RI produces more data on antimicrobial-resistant bacteria than any other research centre in Cameroon, linking human, animal and environmental health to inform policy and practice.

Since2017·Yaoundé, Cameroon
1.27MDeaths attributable to bacterial AMR worldwide in 2019
50+Peer-reviewed articles
11Competitive grants since 2020
5Research programmes

Why bacterial AMR

In 2019, 1.27 million deaths were directly attributable to bacterial antimicrobial resistance, with the highest rates in sub-Saharan Africa. Knowing the real burden of AMR, its resistance mechanisms, transmission routes and the evolution of resistant pathogens is essential for location-specific policy: infection prevention and control, access to essential antibiotics, and the development of new vaccines and antibiotics.

Source: Antimicrobial Resistance Collaborators, The Lancet, 2022.

The gap we fill

Many African countries still lack reliable data on resistant bacteria. Closing this gap requires stronger microbiology laboratories and advanced genomic capacity for scalable, state-of-the-art studies. This is what CEDBCAM-RI builds in Cameroon.

CEDBCAM-RI researchers at work in the molecular biology laboratory
Our teams at work in the CEDBCAM-RI laboratory, Yaoundé.

Our approach

Genomic surveillance
Whole genome sequencing and molecular epidemiology of priority resistant bacteria.

One Health
Linking humans, animals, food and the environment to trace how resistance spreads.

From data to action
Rapid diagnostics, vaccines and infection prevention informed by our evidence.

People and capacity
Training the next generation of African AMR scientists, from Master’s to postdoc.

Phone: (+237) 694043050
Fax: (+237) 673774022
Biyem-assi, Carrefour Saint Marc
Yaounde, Cameroon